Literature DB >> 15507334

Thai medicinal plants modulate nitric oxide and tumor necrosis factor-alpha in J774.2 mouse macrophages.

Khanittha Punturee1, Christopher P Wild, Usanee Vinitketkumneun.   

Abstract

Centella asiatica (CA) and Rhinacanthus nasutus (RN) are Thai medicinal plants traditionally used to treat a variety of disorders including inflammatory conditions and infections. Nitric oxide (NO) produced from activated macrophages plays a role in both inflammatory and anti-inflammatory processes. This study examined whether CA and RN modulate the production of NO and tumour necrosis factor-alpha (TNF-alpha) by J774.2 mouse macrophages. Expression of the inducible nitric oxide synthase (iNOS) and TNF-alpha genes was also analysed. With CA (water extract) NO production was increased in a dose-dependent manner. An increase also occurred when CA was administered with lipopolysaccharide (LPS), a known macrophage activator. In contrast, an ethanol extract of CA had no effect on NO, and when administered with LPS the extract suppressed production. With RN, neither water nor ethanol extracts alone had an effect on NO, although when the ethanol extract of RN was used in combination with LPS, production was increased. TNF-alpha secretion was correlated with NO production and increases were associated with an elevation in TNF-alpha mRNA. The only effect on iNOS gene expression was an inhibition with the CA ethanol extract in the presence of LPS, consistent with the reduction in NO under these conditions. These studies show that CA and RN extracts can either increase or decrease NO production by macrophages and that these effects are predominantly mediated through an effect on TNF-alpha expression. These data contribute to a better mechanistic understanding of the medicinal properties of these Thai plants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507334     DOI: 10.1016/j.jep.2004.06.019

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression.

Authors:  Fangyuan Shi; Shuangyan Duan; Jihong Cui; Xingrong Yan; Hongmin Li; Yingjuan Wang; Fulin Chen; Lihua Zhang; Jun Liu; Xin Xie
Journal:  J Mol Neurosci       Date:  2014-03-30       Impact factor: 3.444

2.  Moringa oleifera pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated RAW 264.7 murine macrophage cell lines.

Authors:  Channarong Muangnoi; Pimjai Chingsuwanrote; Phawachaya Praengamthanachoti; Saovaros Svasti; Siriporn Tuntipopipat
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

3.  Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies.

Authors:  Wipaporn Rojanarat; Narumon Changsan; Ekawat Tawithong; Sirirat Pinsuwan; Hak-Kim Chan; Teerapol Srichana
Journal:  Int J Mol Sci       Date:  2011-07-07       Impact factor: 5.923

4.  In Vitro Antileukemic Activity of Xanthosoma sagittifolium (Taioba) Leaf Extract.

Authors:  Marina L C Caxito; Rachell R Correia; Anne Caroline C Gomes; Graça Justo; Marsen G P Coelho; Cássia M Sakuragui; Ricardo M Kuster; Katia C C Sabino
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-09       Impact factor: 2.629

5.  Rhinacanthus nasutus protects cultured neuronal cells against hypoxia induced cell death.

Authors:  James M Brimson; Tewin Tencomnao
Journal:  Molecules       Date:  2011-07-26       Impact factor: 4.411

6.  Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.

Authors:  Wipaporn Rojanarat; Titpawan Nakpheng; Ekawat Thawithong; Niracha Yanyium; Teerapol Srichana
Journal:  Pharmaceutics       Date:  2012-08-13       Impact factor: 6.321

7.  Centella asiatica modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).

Authors:  Dhaneshree Bestinee Naidoo; Anil Amichund Chuturgoon; Alisa Phulukdaree; Kanive Parashiva Guruprasad; Kapaettu Satyamoorthy; Vikash Sewram
Journal:  BMC Complement Altern Med       Date:  2017-08-01       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.